Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Casodex vs Placebo in Non-Metastatic Prostate Cancer
NCT00672282Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Oct 1995
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of bicalutamide in prostate cancer (PCa), sponsored by AstraZeneca. Started Oct 1995; status: completed.
02
Drugs
bicalutamide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00672282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00672282.